1254 related articles for article (PubMed ID: 32842246)
1. [Analysis of treatment and prognosis of 59 cases of vulvar melanoma].
Yuan GW; Li XG; Li N; Yao HW; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2020 Jun; 55(6):395-401. PubMed ID: 32842246
[No Abstract] [Full Text] [Related]
2. [Investigation of individualized treatment based on sentinel lymph node biopsy for early-stage vulvar cancer].
Tu H; Huang H; Gu H; Wan T; Feng Y; Liu J
Zhonghua Fu Chan Ke Za Zhi; 2015 Aug; 50(8):596-602. PubMed ID: 26675183
[TBL] [Abstract][Full Text] [Related]
3. Vulvar melanoma: report on eleven cases and review of the literature.
Baiocchi G; Duprat JP; Neves RI; Fukazawa EM; Landman G; Guimarães GC; Valadares LJ
Sao Paulo Med J; 2010 Jan; 128(1):38-41. PubMed ID: 20512279
[TBL] [Abstract][Full Text] [Related]
4. [Results of an individualized surgical therapy of vulvar carcinoma from 1973-1993].
Köhler U; Schöne M; Pawlowitsch T
Zentralbl Gynakol; 1997; 119 Suppl 1():8-16. PubMed ID: 9245126
[TBL] [Abstract][Full Text] [Related]
5. Melanoma of the Vulva and Vagina: Surgical Management and Outcomes Based on a Clinicopathologic Reviewof 68 Cases.
Sinasac SE; Petrella TM; Rouzbahman M; Sade S; Ghazarian D; Vicus D
J Obstet Gynaecol Can; 2019 Jun; 41(6):762-771. PubMed ID: 30391279
[TBL] [Abstract][Full Text] [Related]
6. Midline involvement as a risk factor for vulvar cancer recurrence.
Stankevica J; Macuks R; Baidekalna I; Donina S
Asian Pac J Cancer Prev; 2012; 13(10):5237-40. PubMed ID: 23244142
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characterization of vulvar epithelioid sarcoma].
Sun L; Wu LY; Li XG; Bai P; Zhang HT
Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):935-8. PubMed ID: 21223804
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance and prognostic value of femoral lymph node metastasis in FIGO stage III vulvar carcinoma.
Tu H; Sun P; Gu HF; Zhang XK; Huang H; Wan T; Liu JH
Eur J Surg Oncol; 2017 Sep; 43(9):1768-1775. PubMed ID: 28602173
[TBL] [Abstract][Full Text] [Related]
9. Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later.
Verschraegen CF; Benjapibal M; Supakarapongkul W; Levy LB; Ross M; Atkinson EN; Bodurka-Bevers D; Kavanagh JJ; Kudelka AP; Legha SS
Int J Gynecol Cancer; 2001; 11(5):359-64. PubMed ID: 11737466
[TBL] [Abstract][Full Text] [Related]
10. Prognostic variables in the treatment of squamous cell carcinoma of the vulva.
Shimm DS; Fuller AF; Orlow EL; Dosoretz DE; Aristizabal SA
Gynecol Oncol; 1986 Jul; 24(3):343-58. PubMed ID: 3721307
[TBL] [Abstract][Full Text] [Related]
11. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
12. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma.
Parthasarathy A; Cheung MK; Osann K; Husain A; Teng NN; Berek JS; Kapp DS; Chan JK
Gynecol Oncol; 2006 Dec; 103(3):1095-9. PubMed ID: 16889821
[TBL] [Abstract][Full Text] [Related]
13. A clinicopathological study of 30 melanomas of the vulva.
Tasseron EW; van der Esch EP; Hart AA; Brutel de la Rivière G; Aartsen EJ
Gynecol Oncol; 1992 Aug; 46(2):170-5. PubMed ID: 1500018
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
15. Malignant vulvo-vaginal melanoma: a report of 7 cases.
González-Bosquet J; García Jiménez A; Gil Moreno A; Xercavins J
Eur J Gynaecol Oncol; 1997; 18(1):63-7. PubMed ID: 9061328
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment.
Woelber L; Eulenburg C; Choschzick M; Kruell A; Petersen C; Gieseking F; Jaenicke F; Mahner S
Int J Gynecol Cancer; 2012 Mar; 22(3):503-8. PubMed ID: 22266935
[TBL] [Abstract][Full Text] [Related]
17. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
[No Abstract] [Full Text] [Related]
18. Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.
Polterauer S; Schwameis R; Grimm C; Hillemanns P; Jückstock J; Hilpert F; de Gregorio N; Hasenburg A; Sehouli J; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Harter P; Wimberger P; Kölbl H; Reinthaller A; Woelber L; Mahner S
Gynecol Oncol; 2019 May; 153(2):286-291. PubMed ID: 30760408
[TBL] [Abstract][Full Text] [Related]
19. Prognostic indicators in melanoma of the vulva.
Raspagliesi F; Ditto A; Paladini D; Fontanelli R; Stefanon B; Dipalma S; De Palo G
Ann Surg Oncol; 2000 Dec; 7(10):738-42. PubMed ID: 11129421
[TBL] [Abstract][Full Text] [Related]
20. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy.
Burke TW; Levenback C; Coleman RL; Morris M; Silva EG; Gershenson DM
Gynecol Oncol; 1995 May; 57(2):215-20. PubMed ID: 7729737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
